High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Actinic Keratoses Clinical Trial

Official title:

High- and Low-risk Actinic Keratosis Referrals to Secondary Care. Implementation of the General Practitioners Guidelines for Actinic Keratosis Patients.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05976061
• Other study ID #: 2020-2432
• Status: Active, not recruiting
• Start date: March 1, 2021
• Est. completion date: December 1, 2024

Study information

• Verified date: April 2024
• Source: Maastricht University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.

Description:

In the Dutch healthcare system, patients are first examined by the general practitioner who decides whether a referral to a dermatologist is indicated. Both general practitioners and dermatologists can diagnose and treat patients with actinic keratosis. Therefore, it is necessary to distinguish which patients the general practitioner should refer to a dermatologist and which patients are suitable to be treated by the general practitioner.

This retrospective data study evaluates the proportion of low risk actinic keratosis patients in 2019 en 2018.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3379
• Est. completion date: December 1, 2024
• Est. primary completion date: September 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients of 18 years and older

• referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist

• treated at MaastrichtUMC+ or TergooiHospital

Exclusion Criteria:

• different diagnosis than actinic keratosis

• referred by a different specialist than the general practitioner

• referred with multiple problems

• referred for a second opinion

• if the patients was treated as different diagnosis than actinic keratosis by general practitioner

Related Conditions & MeSH terms

• Actinic Keratoses
• Keratosis
• Keratosis, Actinic

Locations

Country	Name	City	State
Netherlands	Ellen Oyen	Maastricht

Sponsors (2)

Lead Sponsor	Collaborator
Maastricht University Medical Center	Tergooi Hospital

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients.	The change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients referred by the general practitioner to the dermatologist. The definition of low-risk actinic keratosis patients was based on the General Practitioners guidelines 'Suspicious skin lesions' (published in 2017). Patients were defined as low-risk when they were not immunocompromised, did not have a cutaneous malignancy in their medical history, did not have previous treatment or if they did not have extensive lesions.	2018 compared to 2019 (2 years)

External Links

•   the Dutch College of General Practitioners guidelines 'Suspicious Skin lesions'. [updated 2020].